Conference Reports for NATAP

AASLD 60th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA, Hynes Convention Center October 30-November 3, 2009 Back

Identifying HCV genotype 2/3 patients who could receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirin       Reported by Jules Levin AASLD Oct 31-Nov 3 2009 Boston, MA   Mitchell L. Shiffman*, Jean-Pierre Bronowicki, Stefan Zeuzem, Maribel Rodriguez-Torres, Stephen C. Pappas, David Nelson, Moises Diago *VCU Medical Center, Richmond, VA, USA